No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Addyi (flibanserin) is a drug used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. It is the first and only FDA-approved drug for this condition. Addyi works by increasing the levels of dopamine and norepinephrine in the brain, which can help to increase sexual desire. It is taken once daily, and can be taken with or without food.
Addyi is part of a growing market of Sexual and Reproductive Health Drugs, which includes products for contraception, fertility, and menopause. These drugs are designed to help women manage their sexual and reproductive health, and can help to improve quality of life.
Companies in the Addyi market include Sprout Pharmaceuticals, Valeant Pharmaceuticals, and Boehringer Ingelheim. Show Less Read more
